GleamWall
中文EN

ICU SeaStar Medical Holding Corp

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1831868 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY145.7%
TTM net income YoY-7.5%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin92.6%
Operating margin-692.4%
Net margin-678.2%
FCF margin—
EBITDA margin—

Returns

ROE-246.1%
ROA-140.9%
ROIC (approx.)—
Asset turnover0.21x

Leverage & solvency

Liabilities / assets91.2%
Debt / equity0.00x
Current ratio1.03x
Interest coverage-516.93x

Cash quality & payout

Operating cash flow / net income0.90x
Accruals ratio-14.0%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$635,000$615,000$495,000$420,000$183,000$338,000$293,000$67,000
Cost of revenue$48,000$54,000$46,000$12,000$14,000$27,000$0$0
Gross profit$587,000$561,000$449,000$408,000$169,000$311,000$293,000$67,000
R&D expense$3.57M$2.52M$2.34M$2.20M$1.85M$1.04M$2.43M$2.74M
SG&A expense$1.59M$1.83M$1.71M$1.22M$1.90M$1.03M$1.68M$2.10M
Operating income-$4.58M-$3.79M-$3.60M-$3.02M-$3.58M-$1.76M-$3.82M-$4.77M
Interest expense$2,000$8,000$6,000$13,000$0$9,000$11,000-$253,000
Pretax income-$4.53M-$3.73M-$3.52M-$2.90M-$3.47M-$2.00M-$3.77M-$4.42M
Income tax$0$0$3,000$0$0$0$3,000$0
Net income-$4.53M-$3.73M-$3.52M-$2.90M-$3.47M-$2.00M-$3.77M-$4.42M
EPS (basic)-1.03-0.91-0.90—-1.30-1.77-4.38—
EPS (diluted)—————-0.18-0.44—
Weighted avg. shares (diluted)—————11.33M8.62M—
Balance sheet
Cash & equivalents$3.99M$6.96M$9.35M$11.98M$13.76M$6.30M$5.30M$1.82M
Receivables$178,000$208,000$179,000$237,000$221,000$217,000$110,000$112,000
Inventory$45,000$77,000$57,000$66,000$83,000$77,000$44,000$0
Current assets$4.97M$8.23M$10.76M$13.58M$14.87M$7.65M$6.78M$3.77M
Total assets$5.31M$8.65M$11.26M$14.16M$15.53M$8.38M$14.20M$4.66M
Current liabilities$4.84M$4.35M$3.95M$3.74M$4.07M$5.04M$7.03M$6.84M
Short-term debt———————$574,000
Total liabilities$4.84M$4.35M$3.95M$3.74M$4.07M$5.04M$7.03M$6.84M
Shareholders' equity$469,000$4.30M$7.32M$10.42M$11.46M$3.34M$565,000-$2.18M
Shares outstanding4.46M4.26M3.99M3.84M34.10M17.34M9.26M650,639
Cash flow statement
Operating cash flow-$3.37M-$2.99M-$2.76M-$4.09M-$3.84M-$3.01M-$2.65M-$4.69M
Financing cash flow$403,000$605,000$129,000$2.31M$11.30M$4.01M$6.13M$4.43M
Stock-based compensation$163,000-$99,000$91,000$70,000$290,000$97,000$167,000$212,000

Free plan shows the latest 8 periods; Pro shows all 23 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.